Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are largely involved in the neural transmission of synapses and their inhibitors have been identified as targets in the treatment of neurodegenerative disorders, including Alzheimer’s diseases and myasthenia gravis [58]. Here, ACHE is linked to Alzheimer disease.